KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |
| COMMODORE CAPITAL LP | 1,400,000 | $12,768,000 | 1.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 703,287 | $6,413,977 | 1.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,374,044 | $39,891,281 | 0.88% |
| Artal Group S.A. | 2,018,056 | $18,405 | 0.79% |
| Paradigm Biocapital Advisors LP | 1,212,828 | $11,060,991 | 0.75% |
| 1492 Capital Management LLC | 100,466 | $916,250 | 0.59% |
| Avoro Capital Advisors LLC | 2,980,000 | $27,177,600 | 0.42% |
| ARMISTICE CAPITAL, LLC | 2,236,000 | $20,392,320 | 0.31% |
| MYDA Advisors LLC | 80,000 | $729,600 | 0.24% |
| ALGERT GLOBAL LLC | 365,024 | $3,329 | 0.16% |
External links
This page lists KURA ONCOLOGY INC's shareholders in Q3 2023. To view KURA ONCOLOGY INC's shareholder history, click here.